Sedative load and anticholinergic burden among older adults in Slovenia over a decade: Potential for optimization of pharmacotherapy

1 World Health Organization. World report on ageing and health. 2015; https://apps.who.int/iris/bit-stream/handle/10665/186463/9789240694811_eng.pdf;jsessionid=7A8E7FB612B2F4EF59F-7663CE04E54CE?sequence=1; last access date June 26, 2023. Search in Google Scholar

2 Republic of Slovenia Statistical Office. SiStat. 2024; https://pxweb.stat.si/SiStat/en; last access date January 25, 2024. Search in Google Scholar

3 A. Mangoni, P. Jansen and S. Jackson, Chapter 1 – Clinical Pharmacology of Aging, in Prescribing for Elderly Patients (Ed. S. Jackson, P. Jansen, A. Mangoni), John Wiley & Sons, New York 2009, pp. 1–12. Search in Google Scholar

4 A. Al Hamid, M. Ghaleb, H. Aljadhey and Z. Aslanpour, A systematic review of hospitalization resulting from medicine-related problems in adult patients, Br. J. Clin. Pharmacol. 78(2) (2014) 202–217; https://doi.org/10.1111/bcp.12293 Search in Google Scholar

5 L. E. Davies, G. Spiers, A. Kingston, A. Todd, J. Adamson and B. Hanratty, Adverse outcomes of polypharmacy in older people: Systematic review of reviews, J. Am. Med. Dir. Assoc. 21(2) (2020) 181–187; https://doi.org/10.1016/j.jamda.2019.10.022 Search in Google Scholar

6 L. Kouladjian, D. Gnjidic, T. F. Chen, A. A. Mangoni and S. N. Hilmer, Drug Burden Index in older adults: Theoretical and practical issues, Clin. Interv. Aging 9 (2014) 1503–1515; https://doi.org/10.2147/CIA.S66660 Search in Google Scholar

7 J. Peklar, A. M. O’Halloran, I. D. Maidment, M. C. Henman, R. A. Kenny and M. Kos, Sedative load and frailty among community-dwelling population aged >= 65 years, J. Am. Med. Dir. Assoc. 16(4) (2015) 282–289; https://doi.org/10.1016/j.jamda.2014.10.010 Search in Google Scholar

8 H. T. Taipale, J. S. Bell, M. Uusi-Kokko, E. Lonnroos, R. Sulkava and S. Hartikainen, Sedative load among community-dwelling people aged 75 years and older: A population-based study, Drugs Aging 28(11) (2011) 913–925; https://doi.org/10.2165/11597800-000000000-00000 Search in Google Scholar

9 T. West, M. C. Pruchnicki, K. Porter and R. Emptage, Evaluation of anticholinergic burden of medications in older adults, J. Am. Pharm. Assoc. 53 (2003) 496–504; https://doi.org/10.1331/JAPhA.2013.12138 Search in Google Scholar

10 D. Gnjidic, D. G. Le Couteur, S. A. Pearson, A. J. McLachlan, R. Viney, S. N. Hilmer, F. M. Blyth, G. Joshy and E. Banks, High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level, BMC Public Health. 13 (2013) Article ID 115 (9 pages); https://doi.org/10.1186/1471-2458-13-115 Search in Google Scholar

11 C. E. Durán, M. Azermai and R. H. V. Stichele, Systematic review of anticholinergic risk scales in older adults, Eur. J. Clin Pharmacol. 69(7) (2013) 1485–1496; https://doi.org/10.1007/s00228-013-1499-3 Search in Google Scholar

12 T. Linjakumpu, S. Hartikainen, T. Klaukka, H. Koponen, S. L. Kivelä, R. Isoaho, A model to classify the sedative load of drugs, Int. J. Geriatr. Psychiatry 18(6) (2003) 542–544; https://doi.org/10.1002/gps.846 Search in Google Scholar

13 M. Boustani, N. Campbell, S. Munger, I. Maidment and C. Fox, Impact of anticholinergics on the aging brain: A review and practical application, Aging Health 4(3) (2008) 311–320; https://doi.org/10.2217/1745509X.4.3.311 Search in Google Scholar

14 N. Campbell, I. Maidment, C. Fox, B. Khan and M. Boustani, The 2012 update to the anticholinergic cognitive burden scale, J. Am. Geriatr. Soc. 61(S1) (2013) S1:S142–S143; https://doi.org/10.1111/jgs.2013.61.issue-s1 Search in Google Scholar

15 H. T. Taipale, J. S. Bell, D. Gnjidic, R. Sulkava and S. Hartikainen, Sedative load among community--dwelling people aged 75 years or older: Association with balance and mobility, J. Clin. Psycho­pharmacol. 32(2) (2012) 218–224; https://doi.org/10.1097/JCP.0b013e3182485802 Search in Google Scholar

16 L. Kouladjian, D. Gnjidic, E. Reeve, T. F. Chen and S. N. Hilmer, Health care practitioners’ perspectives on deprescribing anticholinergic and sedative medications in older adults, annals of pharmacotherapy, 50(8) (2016) 625–636; https://doi.org/10.1177/1060028016652997 Search in Google Scholar

17 S. B. Al Rihani, M. Deodhar, L. I. Darakjian, P. Dow, M. K. Smith, R. Bikmetov, J. Turgeon and V. Michaud, Quantifying anticholinergic burden and sedative load in older adults with polypharmacy: A systematic review of risk scales and models, Drugs Aging 38(11) (2021) 977–994; https://doi.org/10.1007/s40266-021-00895-x Search in Google Scholar

18 C. Fox, K. Richardson, I. D. Maidment, G. M. Savva, F. E. Matthews, D. Smithard, S. Coulton, C. Katona, M. A. Boustani and C. Brayne, Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study, J. Am. Geriatr. Soc. 59(8) (2011) 1477–1483; https://doi.org/10.1111/j.1532-5415.2011.03491.x Search in Google Scholar

19 N. L. Campbell, A. J. Perkins, P. Bradt, S. Perk, R. C. Wielage, M. A. Boustani and D. B. Ng, Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population, Pharmacotherapy 36(11) (2016) 1123–1131; https://doi.org/10.1002/phar.1843 Search in Google Scholar

20 Y. B. Zheng, L. Shi, X. M. Zhu, Y. P. Bao, L. J. Bai, J. Q. Li, J. J. Liu, Y. Han, J. Shi and L. Lu, Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis, Neurosci. Biobehavioral Reviews 127 (2021) 296–306; https://doi.org/10.1016/j.neubiorev.2021.04.031 Search in Google Scholar

21 A. Nakham, P. K. Myint, C. M. Bond, R. Newlands, Y. K. Loke and M. Cruickshank, Interventions to reduce anticholinergic burden in adults aged 65 and older: A systematic review, J. Am. Med. Dir. Assoc. 21(2) (2020) 172–180; https://doi.org/10.1016/j.jamda.2019.06.001 Search in Google Scholar

22 S. N. Hilmer and D. Gnjidic, The anticholinergic burden: from research to practice, Australi Prescr. 45(4) (2022) 118–120; https://doi.org/10.18773/austprescr.2022.031 Search in Google Scholar

23 J. S. Bell, C. Mezrani, N. Blacker, T. LeBlanc, O. Frank, C. P. Alderman, S. Rossi, D. Rowett and R. Shute, Anticholinergic and sedative medicines: Prescribing considerations for people with dementia, Aust. Fam. Physician. 41(1–2) (2012) 45–49. Search in Google Scholar

24 J. Mur, S. R. Cox, R. E. Marioni, G. Muniz-Terrera and T. C. Russ, Increase in anticholinergic burden from 1990 to 2015: Age-period-cohort analysis in UK biobank, Br. J. Clin. Pharmacol. 88(3) (2022) 983–993; https://doi.org/10.1111/bcp.15045 Search in Google Scholar

25 U. L. Aalto, H. M. Roitto, H. Finne-Soveri, H. Kautiainen and K. H. Pitkälä, Temporal trends in the use of anticholinergic drugs among older people living in long-term care facilities in Helsinki, Drugs Aging 37(1) (2020) 27–34; https://doi.org/10.1007/s40266-019-00720-6 Search in Google Scholar

26 A. Iaboni, S. E. Bronskill, K. B. Reynolds, X. Wang, P. A. Rochon, N. Herrmann and A. J. Flint, Changing pattern of sedative use in older adults: A population-based cohort study, Drugs Aging 33(7) (2016) 523–533; https://doi.org/10.1007/s40266-016-0380-3 Search in Google Scholar

27 H. M. Roitto, H. Kautiainen, U. L. Aalto, H. Öhman, J. Laurila and K. H. Pitkälä, Fourteen-year trends in the use of psychotropic medications, opioids and other sedatives among institutionalized older people in Helsinki, Finland, J. Am. Med. Dir. Assoc. 20(3) (2019) 305–311; https://doi.org/10.1016/j.jamda.2018.12.022 Search in Google Scholar

28 C. L. Kuo, I. C. Chien and C. H. Lin, Trends, correlates and disease patterns of sedative-hypnotic use among elderly persons in Taiwan, BMC Psychiatry 22(1) (2022) Article ID 316 (8 pages); https://doi.org/10.1186/s12888-022-03964-6 Search in Google Scholar

29 D. T. Maust, F. C. Blow, I. R. Wiechers, H. C. Kales and S. C. Marcus, National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care, J. Clin. Psychiatry 78(4) (2017) e363-e371; https://doi.org/10.4088/JCP.16m10713 Search in Google Scholar

30 C. N. Kaufmann, A. P. Spira, G. C. Alexander, L. Rutkow and R. Mojtabai, Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010, Pharmacoepidemiol. Drug Saf. 25(6) (2016) 637–645; https://doi.org/10.1002/pds.3951 Search in Google Scholar

31 E. Gosselin, M. Simard, C. Lunghi and C. Sirois, Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada, Pharmacoepidemiol. Drug Saf. 31(3) (2022) 322–333; https://doi.org/10.1002/pds.5383 Search in Google Scholar

32 M. O. Rinkinen, H. M. Roitto, H. R. Öhman, H. J. Kautiainen, R. S. Tilvis, T. E. Strandberg, K. H. Pitkala and U. L. Aalto, Temporal trends over two decades in the use of anticholinergic drugs among older community-dwelling people in Helsinki, Finland, Drugs Aging 39(9) (2022) 705–713; https://doi.org/10.1007/s40266-022-00968-5 Search in Google Scholar

33 K. H. Pitkala, A. L. Juola, H. Hosia, M. Teramura-Gronblad, H. Soini, N. Savikko and J. S. Bell, Eight--year trends in the use of opioids, other analgesics and psychotropic medications among institutionalized older people in Finland, J. Am. Med. Dir. Assoc. 16(11) (2015) 973–978; https://doi.org/10.1016/j.jamda.2015.06.009 Search in Google Scholar

34 S. de Germay, M. Rueter, F. Montastruc, V. Rousseau, M. Lapeyre-Mestre and J. L. Montastruc, Trends of atropinic (anticholinergic) exposure in the elderly: A 10-year analysis in the French EGB database, Fundam. Clin. Pharmacol. 33(4) (2019) 471–478; https://doi.org/10.1111/fcp.12450 Search in Google Scholar

35 Health Insurance Institute of Slovenia, Poslovno poročilo za leto 2015. Ljubljana. 2016; http://www.zzzs.si/ZZZS/info/egradiva.nsf/0/7868d258ee297a14c12580d5003e95b3/$FILE/Poslovno%20poro%C4%8Dilo%20ZZZS%20za%20leto%202016_24.3.2017.pdf; last access date January 25, 2024. Search in Google Scholar

36 J. Jazbar, I. Locatelli, N. Horvat and M. Kos, Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study, Res. Soc. Admin. Pharmacy 14(6) (2018) 572–580; https://doi.org/10.1016/j.sapharm.2017.07.004 Search in Google Scholar

37 N. Marđetko and M. Kos, Introduction of therapeutic reference pricing in Slovenia and its economic consequences, Eur. J. Health Econom. 19(4) (2018) 571–584; https://doi.org/10.1007/s10198-017-0903-9 Search in Google Scholar

38 PCNE Newsletter, 2017; http://www.pcne.org/upload/files/174_PCNE_news_2016-4.pdf; last access date June 26, 2023. Search in Google Scholar

39 C. Parsons, J. Haydock, E. Mathie, N. Baron, I. Machen, E. Stevenson, S. Amador and C. Goodman, Sedative load of medications prescribed for older people with dementia in care homes, BMC Geriatr. 11 (2011) Article ID 56 (12 pages); https://doi.org/10.1186/1471-2318-11-56 Search in Google Scholar

40 M. S. Salahudeen, S. B. Duffull and P. S. Nishtala, Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: A systematic review, BMC Geriatr. 15(1) (2015) Article ID 31 (14 pages); https://doi.org/10.1186/s12877-015-0029-9 Search in Google Scholar